Skip to content
    PRVA
    Earnings call· Jun 2026(Q2 FY26)

    Privia Health Group Q2 FY26 earnings call PRVA

    Aug 6, 2026 Source

    Executive summary

    Privia Health Q2 FY26 — Strong Growth and Raised Full-Year Outlook

    Privia Health delivered a strong Q2 FY26, driven by robust provider and attributed lives growth, leading to a 29% increase in adjusted EBITDA and significant margin expansion. The company raised its full-year outlook across all key financial metrics, reflecting confidence in its execution and diversified value-based care model. Management highlighted the continued expansion of its national footprint and the strategic deployment of AI applications to enhance operational efficiency and drive further margin accretion.

    Highlights

    5
    • Implemented provider growth of 10.1% year-over-year to 5,644.

    • Value-based attributed lives growth of 19.2% year-over-year to 1.64 million.

    • Adjusted EBITDA increased 29% year-over-year to $37.4 million.

    • EBITDA margin as a percentage of care margin expanded 310 basis points to 28.3%.

    • Raised 2026 outlook across all key financial metrics, with attributed lives above prior guidance.

    Concerns

    2
    • Potential delay in CMS Medicare Shared Savings Program cash settlement for 2025 performance until November.

    • Implied deceleration in practice collections growth from 13.4% in 1H to approximately 3% in 2H, attributed by management to prudence.

    Guidance & targets

    9
    CategoryTargetConfidence
    Full-year 2026 Practice Collections
    High end of prior guidance range
    medium materiality
    Medium
    Full-year 2026 GAAP Revenue
    High end of prior guidance range
    medium materiality
    Medium
    Full-year 2026 Care Margin
    Mid- to high end of prior guidance range
    medium materiality
    Medium
    Full-year 2026 Platform Contribution
    Mid- to high end of prior guidance range
    medium materiality
    Medium
    Full-year 2026 Adjusted EBITDA
    Mid- to high end of prior guidance range
    medium materiality
    Medium
    Full-year 2026 Attributed Lives
    Above the high end of prior guidance
    medium materiality
    Medium
    Full-year 2026 Implemented Providers
    570 providers at midpoint
    medium materiality
    Medium
    Long-term EBITDA margin as % of care margin
    Expand towards the high end of 30% to 35%
    high materiality
    Medium
    Full-year 2026 Free Cash Flow Conversion
    70% to 80% of full year adjusted EBITDA
    medium materiality
    Medium

    Operational metrics

    19
    Implemented providers
    5,644+10.1% YoY
    Q2 FY26

    Total implemented providers at June 30.

    Total practice collections
    $970 million+12.4% YoY
    Q2 FY26

    Driven by implemented provider growth, strong ambulatory utilization, and value-based performance.

    Adjusted EBITDA
    $37.4 million+29% YoY
    Q2 FY26

    Reconciled to GAAP net income in the appendix.

    EBITDA margin as % of care margin
    28.3%+310 bps YoY
    Q2 FY26

    Reflects operating leverage across cost of platform and G&A.

    Cash and investments balance
    $412 million
    Q2 FY26

    Provides significant financial flexibility for capital deployment.

    Total medical spend managed
    $15.7 billion
    Q2 FY26

    Estimated across all commercial and government value-based risk arrangements.

    Commercial attributed lives
    942,000+11.7% YoY
    Q2 FY26

    Part of the diversified value-based care contracts.

    CMS Medicare attributed lives growth
    Up 55%
    Q2 FY26

    Part of the diversified value-based care contracts.

    Medicare Advantage attributed lives growth
    More than 12%
    Q2 FY26

    Part of the diversified value-based care contracts.

    Medicaid attributed lives growth
    More than 18%
    Q2 FY26

    Part of the diversified value-based care contracts.

    Implemented provider growth (midpoint of 2026 guidance)
    570+10.6% over 2025
    FY26

    Midpoint of 2026 guidance, unchanged from prior.

    Gross provider retention
    98%
    Past 3 years

    A defining component of Privia's operating model.

    Provider expenses
    $500 million
    Q2 FY26

    Payments passed through to providers on fee-for-service and value-based books.

    Cost of platform as % of care margin
    52.5%-400 bps YoY
    Q2 FY26

    Reflects operating leverage and efficiency gains.

    Business locked in for following year guidance
    90%
    FY27

    Refers to fee-for-service basis by the time following year guidance is given in February.

    Total Addressable Market (TAM) for clinicians
    1.1 million
    Long-term

    Even if addressable TAM is half of that, it's 600,000 providers, compared to Privia's ~6,000.

    Productivity lift for physicians
    10% to 20%
    Long-term

    Achieved as physicians spend less time on technology, payer contracts, and administrative tasks.

    Practice size increase
    2x to 3x
    5-7 year period

    Organic growth for practices by adding providers, expanding patient panels, and adding locations/specialists.

    Free cash flow conversion
    70% to 80%
    FY26

    Of full year adjusted EBITDA; assumes receipt of 2025 shared savings cash payments by year-end and excludes capital deployment for business development.

    Industry KPIs

    3
    MetricValueDetails
    Utilization trendsStrongdirectional
    Membership covered lives by line1.64 millionlives
    Adjusted EPS EBITDA leverage guidance28.3%%

    Deals & partnerships

    1
    Urology Group of Bergen CountyEntry into the state of New Jersey

    Partnership with a practice of 25 adult and pediatric clinicians, representing Privia's 25th state. Expected to be a 5-10 year play to build local density.

    Risks & headwinds

    1
    Delay in CMS Medicare Shared Savings Program cash settlementQ4 FY26

    Delivery of final reconciliation results for performance year 2025 may be delayed until November.

    Mitigation: Management is confident in receiving the money, viewing it as a timing issue (30-45 days delay) due to proposed changes, not a concern about payment. It has minimal impact on accruals.

    What to watch in Q3 FY26

    4

    CMS Shared Savings Cash Settlement

    Q4 FY26
    CurrentDelayed until November for 2025 performance year
    TargetReceipt of cash settlement by year-end

    Why it matters

    Impacts year-end cash flow dynamics and free cash flow conversion.

    While this has minimal impact on our accruals, it may lead to an atypical year-end cash flow dynamic, depending on when we receive the cash settlement from CMS as well as our subsequent payments to the providers.

    Q&A highlights

    5

    What gives you confidence that the delayed CMS shared savings payment will come in Q4, and what external signposts should we watch?

    Management expressed confidence, noting CMS has been reliable in the past. The delay is due to proposed changes, not a concern about payment, and is expected to be 30-45 days. They believe it's in CMS's interest to ensure providers receive cash flow for good performance.

    I mean we're not that worried about it. They've been really good over the past many years. Usually, results come in August, September. The cash settlement happens sometime October. So it's delayed by, call it, 30 to 45 days.

    asked by Elizabeth Anderson · answered by Parth Mehrotra

    2 min read6 chapters

    Detailed Narrative

    01

    Strong Operational Execution and Growth

    Privia Health continued its strong execution, delivering significant growth in implemented providers and attributed lives. The company's footprint expanded to 25 states and D.C., with 5,644 implemented providers and 1.64 million attributed lives, demonstrating consistent growth and market penetration. Gross provider retention averaged 98% over the past three years, contributing to predictable business performance.

    02

    Value-Based Care Expansion and Impact

    The company serves over 1.64 million attributed lives across more than 130 commercial and government value-based care programs, managing an estimated $15.7 billion in total medical spend. Diversification across commercial, Medicare, and Medicaid programs provides confidence in scaling profitability without reliance on a single program. Management highlighted the ability to transform fee-for-service payments into multi-set payments, including care management fees and shared savings.

    03

    AI Integration for Efficiency and Margin Expansion

    Privia is actively deploying AI applications across various workflows, including corporate functions, fee-for-service, value-based care, and patient experience. This initiative is expected to drive further EBITDA margin expansion towards the high end of the 30-35% long-term target by improving efficiency, reducing administrative tasks, and limiting headcount growth. The company is piloting various applications and measuring tangible benefits in time saved and outcomes achieved.

    04

    Strategic Market Entry and Acquisitions

    The entry into New Jersey in partnership with the Urology Group of Bergen County, a practice with 25 clinicians, marks the 25th state for Privia, reinforcing its national primary care-centric network strategy. Recent acquisitions like Evolent and IMS are progressing well, contributing to growth and expanding the company's capabilities, particularly in the ACO-only model, which allows for broader market conversations and potential tuck-in acquisitions.

    05

    Prudent Guidance and Future Outlook

    Management raised its 2026 outlook across all key financial metrics, including practice collections, care margin, and EBITDA, reflecting strong first-half performance. While the implied H2 growth rate for practice collections suggests deceleration, management attributes this to prudence and anticipates potential upside if current trends continue. The company maintains a robust pipeline for existing market expansion and new opportunities.

    06

    Strengthening Physician Value Proposition

    Privia's value proposition for physicians continues to strengthen, offering better fee-for-service contract rates, significant expense savings on technology, and efficiency gains, leading to a 10-20% productivity lift. The sophisticated value-based care machinery allows providers to participate across the entire patient panel, transforming payments and enabling organic practice growth, with some practices doubling in size over 5-7 years.

    AI-generated summary of the company’s earnings call. Not investment advice.